Biotech Investors: When Will They Ever Learn?

Biotech Investors: When Will They Ever Learn? Investors should get a grip on reality. Many small companies that were lifted on the latest news are strapped for cash and pursuing risky science that will take years to bear fruit. Even for big players, good trial data on a drug don’t guarantee Food & Drug Administration […]


Drug ads deliver a few side effects

Drug ads deliver a few side effects Drug companies tripled their advertising budgets in recent years to acquaint American consumers with things like acid reflux disease, depression, erectile dysfunction, and even toenail fungus, a marketing blitz that accounted for roughly 12 percent of the growth in national prescription drug spending in 2000, according to a […]


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog